Metformin News and Research

RSS

Metformin is the active ingredient in a drug used to treat diabetes mellitus (a condition in which the body cannot control the level of sugar in the blood). It is also being studied in the treatment of cancer. It decreases the amount of glucose (a type of sugar) released into the bloodstream from the liver and increases the body’s use of the glucose. Metformin is a type of antidiabetic agent.

Advancing medical treatment with causal machine learning

Machines can learn not only to make predictions, but also to handle causal relationships. An international research team shows how this could make therapies safer, more efficient, and more individualized.

25 Apr 2024

Aster DM Healthcare reveals top foods to combat PCOS symptoms

Google searches related to Polycystic Ovary Syndrome (PCOS) reached an all-time high in April 2024 globally, indicating a growing concern and interest in understanding and managing this condition.

23 Apr 2024

Healthy eating, physical activity, and medication: Type 2 diabetes patients' willingness to engage varies

The willingness to engage in various management options for T2D among recently diagnosed patients.

8 Apr 2024

GRADE study reveals key findings in diabetes medication efficacy

Diabetes affects more than 1 in 10 -; or more than 38 million -; Americans. People with diabetes who keep their blood sugar levels in the near-normal range generally have a much lower risk of developing diabetes complications such as heart, kidney, and eye diseases.

26 Mar 2024

Metformin boosts appetite-suppressing metabolite, new study finds

Metformin treatment boosts levels of Lac-Phe, an appetite-suppressing metabolite, potentially offering new insights into its mechanism and opening doors for obesity treatments.

19 Mar 2024

Unlocking weight loss through exercise mimicry with metformin

An "anti-hunger" molecule produced after vigorous exercise is responsible for the moderate weight loss caused by the diabetes medication metformin, according to a new study in mice and humans.

18 Mar 2024

Mouse models shed light on the effects of metformin use during pregnancy on offspring

With the rise in gestational diabetes and metabolic disorders during pregnancy, metformin is also being prescribed more frequently.

18 Mar 2024

Unraveling the complexities of muscle repair in diabetes: A call for targeted research and therapies

Review outlines the impact of diabetes on skeletal muscle regeneration, highlighting the need for focused research and innovative therapies to tackle this growing health issue.

17 Mar 2024

AI-based model enhances efficiency of Type II diabetes prevention efforts

Better prevention of Type II diabetes could save both lives and money. The U.S. spends over $730 billion a year -; nearly a third of all health care spending -; on treating preventable diseases like diabetes.

28 Feb 2024

ChatGPT aids in discovering potential Alzheimer’s treatments through drug repurposing

ChatGPT-4 to identify drug repurposing candidates against Alzheimer’s disease (AD).

28 Feb 2024

Spirulina shows promise in battling heart disease and diabetes

Researchers show Spirulina's therapeutic benefits, including anti-inflammatory and antidiabetic properties, can significantly lower cardiovascular disease risk.

26 Feb 2024

The effectiveness of statins in PCOS management

The application of statins in the treatment of polycystic ovary syndrome (PCOS).

1 Feb 2024

New review aims to help clinicians diagnose and manage PCOS

A recent review article in CMAJ explores the state of current knowledge on the diagnosis and treatment of this chronic disorder.

30 Jan 2024

New review aims to help clinicians diagnose and manage polycystic ovarian syndrome

A new review in CMAJ (Canadian Medical Association Journal) is aimed at helping clinicians diagnose and manage polycystic ovarian syndrome (PCOS), an endocrine disorder that affects about 10% of females.

29 Jan 2024

Scientific review explores adzuki beans' efficacy in diabetes prevention and management

Adzuki bean (Vigna angularis) supplementation to prevent and manage type 2 diabetes (T2D).

25 Jan 2024

Social isolation poses greater mortality risk than loneliness in obese individuals, study finds

A study in "JAMA Network Open" reveals that social isolation, more than loneliness, is strongly associated with increased mortality risk in obese individuals compared to those with normal weight.

24 Jan 2024

Scientists discover key brain cells affected by COVID-19

A recent Cell Stem Cell study investigated whether SARS-CoV-2 infection leads to dopaminergic neuron senescence.

22 Jan 2024

Study identifies more than 200 new genes linked to depression

More than 200 genes linked to depression have been newly identified in a worldwide study led by UCL researchers.

10 Jan 2024

New research project seeks to find innovative treatment pathways for Type 2 diabetes and obesity

A team of Virginia Tech researchers was awarded nearly $2 million from the National Institute of Diabetes and Digestive and Kidney Disease, part of the National Institutes of Health, to explore novel approaches for treating Type 2 diabetes and obesity.

3 Jan 2024

How safe are GLP-1R agonists in early pregnancy?

JAMA Internal Medicine study examines the safety of GLP-1 receptor agonists and other second-line antidiabetic medications during early pregnancy, finding no significant increase in congenital anomalies compared to insulin use.

14 Dec 2023